Allison Gaudy

First Clinical Study of the B-Cell Maturation Antigen (BCMA) 2+1 T Cell Engager (TCE) CC-93269 in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Interim Results of a Phase 1 Multicenter Trial

Luciano J. Costa, Sandy W. Wong, Arancha Bermúdez et al. · Blood · 2019 · 158 citations

Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling

Alicia H. Clementi, Allison Gaudy, Nico van Rooijen et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2009 · 92 citations · Full text

Obesity, Metabolic Syndrome, Inflammation +14

Alnuctamab (ALNUC; BMS-986349; CC-93269), a B-Cell Maturation Antigen (BCMA) x CD3 T-Cell Engager (TCE), in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Results from a Phase 1 First-in-Human Clinical Study

Sandy W. Wong, Noffar Bar, Laura París et al. · Blood · 2022 · 67 citations

Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial

Charlotte M. Niemeyer, Christian Flotho, Daniel B. Lipka et al. · Blood Advances · 2021 · 53 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Azacitidine Monotherapy +21

Biological impact of iberdomide in patients with active systemic lupus erythematosus

Peter E. Lipsky, Ronald van Vollenhoven, Thomas Dörner et al. · Annals of the Rheumatic Diseases · 2022 · 35 citations · Full text